Jang J J, Cho K J, Lee Y S, Bae J H
Department of Anatomical Pathology, Korea Cancer Center Hospital, Seoul.
J Korean Med Sci. 1991 Mar;6(1):31-6. doi: 10.3346/jkms.1991.6.1.31.
The modifying potential of capsaicin (CAP) on lesion development was examined in a rat multiorgan carcinogenesis model. Groups 1 and 2 were treated sequentially with diethylnitrosamine (DEN) (100 mg/kg, ip, single dose at commencement), N-methylnitrosourea (MNU) (20 mg/kg, ip, 4 doses at days 2, 5, 8, and 11), and N,N-dibutylnitrosamine (DBN) (0.05% in drinking water during weeks 3 and 4). Group 3 received vehicles without carcinogens during the initiation period. Group 4 served as the untreated control. After this initiating procedure, Groups 2 and 3 were administered a diet containing 0.01% CAP. All surviving animals were killed 20 weeks after the beginning of the experiment and the target organs examined histopathologically. The induction of GST-P+ hepatic foci in rats treated with carcinogens was significantly inhibited by treatment with CAP. CAP treatment significantly decreased the incidence of adenoma of the lung but increased the incidence of papillary or nodular (PN) hyperplasia of the urinary bladder. The tumor incidence of other organs, such as the kidney and thyroid, was not significantly different from the corresponding controls. These results demonstrated that concurrent treatment with CAP not only can inhibit carcinogenesis but can also enhance it depending on the organ. Thus, this wide-spectrum initiation model could be used to confirm organ-specific modification potential and, in addition, demonstrate different modifying effects of CAP on liver, lung, and bladder carcinogenesis.
在大鼠多器官致癌模型中研究了辣椒素(CAP)对病变发展的修饰作用。第1组和第2组依次接受二乙基亚硝胺(DEN)(100 mg/kg,腹腔注射,开始时单剂量)、N-甲基亚硝基脲(MNU)(20 mg/kg,腹腔注射,在第2、5、8和11天共4剂)以及N,N-二丁基亚硝胺(DBN)(在第3和第4周的饮用水中浓度为0.05%)。第3组在启动期接受不含致癌物的赋形剂。第4组作为未处理对照。在这个启动程序之后,第2组和第3组给予含0.01% CAP的饮食。在实验开始20周后处死所有存活动物,并对靶器官进行组织病理学检查。用CAP处理可显著抑制用致癌物处理的大鼠中GST-P+肝灶的诱导。CAP处理显著降低了肺癌的发生率,但增加了膀胱乳头状或结节状(PN)增生的发生率。其他器官如肾脏和甲状腺的肿瘤发生率与相应对照组无显著差异。这些结果表明,与CAP同时处理不仅可以抑制致癌作用,还可以根据器官不同增强致癌作用。因此,这种广谱启动模型可用于确认器官特异性修饰潜力,此外,还可证明CAP对肝脏、肺和膀胱癌发生的不同修饰作用。